enVVeno Medical Files Prospectus To Offer And Sell Securities For Up To $100M
-SEC Filing
Stocks · News reference
8-K filing — enVVeno Medical Corp (NVNO)
Filed: 2026-07-14 AccNo: 0001493152-26-033193 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
enVVeno Announces Publication Of Peer-Reviewed Health Economics Study Supporting Venous Valve Therapy; Findings May Support Future Coverage And Reimbursement Decisions
Published economic health study shows both short- and long-term cost-effectiveness of replacement venous value therapy versus standard-of-care treatments for deep venous CVI, generating compelling evidence that will be
enVVeno Medical Says Peer-Reviewed Study Projects More Than $32K In Healthcare Savings Per Patient Over Five Years From Venous Valve Replacement Therapy
enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY